SEC
SlamSEC
SearchBrowseEarnings

Inhibikase Therapeutics, Inc.

Nasdaq:IKT
Biological Products, (No Diagnostic Substances)·WILMINGTON, DE
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(327 total)

TypeDateAccessionPeriodSize
4
Feb 24, 2026
0001193125-26-0680794
Feb 21, 2026
5.3 KB
4
Feb 24, 2026
0001193125-26-0680774
Feb 21, 2026
5.1 KB
4
Feb 24, 2026
0001193125-26-0680634
Feb 21, 2026
5.7 KB
SCHEDULE 13G/A
Feb 17, 2026
0001104659-26-016623
—
14.2 KB
SCHEDULE 13G/A
Feb 17, 2026
0001104659-26-016478
—
18.6 KB
SCHEDULE 13G/A
Feb 17, 2026
0001193125-26-054524
—
11.4 KB
SCHEDULE 13G/A
Feb 13, 2026
0001104659-26-015334
—
10.7 KB
SCHEDULE 13G/A
Feb 13, 2026
0001875620-26-000002
—
19.0 KB
4
Jan 7, 2026
0001193125-26-0063514
Jan 5, 2026
5.1 KB
4
Jan 7, 2026
0001193125-26-0063504
Jan 5, 2026
5.2 KB
4
Jan 7, 2026
0001193125-26-0063434
Jan 5, 2026
5.2 KB
SCHEDULE 13G
Dec 31, 2025
0001493152-25-029834
—
23.6 KB
8-K
Dec 19, 2025
0001193125-25-3269168-K
Dec 19, 2025
153.3 KB
424B5
Dec 19, 2025
0001193125-25-326883424B5
—
602.3 KB
4
Nov 24, 2025
0001875620-25-000025PRIMARY DOCUMENT
Nov 21, 2025
11.9 KB
8-K
Nov 21, 2025
0001193125-25-2914438-K
Nov 20, 2025
630.4 KB
424B5
Nov 21, 2025
0001193125-25-291433424B5
—
772.3 KB
424B5
Nov 20, 2025
0001193125-25-289894424B5
—
773.4 KB
8-K
Nov 20, 2025
0001193125-25-2897688-K
Nov 20, 2025
11.3 MB
10-Q
Nov 14, 2025
0001193125-25-28316910-Q
Sep 30, 2025
8.3 MB
8-K
Nov 14, 2025
0001193125-25-2830758-K
Nov 14, 2025
249.6 KB
3/A
Aug 28, 2025
0001193125-25-1914653/A
Feb 21, 2025
4.9 KB
3/A
Aug 28, 2025
0001193125-25-1914643/A
Feb 21, 2025
5.1 KB
4
Aug 28, 2025
0001193125-25-1914634
Feb 21, 2025
5.9 KB
SCHEDULE 13G/A
Aug 14, 2025
0001104659-25-078859
—
14.2 KB
25 filings shown